COMPOUND AND ITS COMPLEX WITH RADIONUCLIDE less than sup greater than 177 less than /sup greater than Lu FOR THERANOSTICS OF TUMORS EXPRESSING ON HER2 RECEPTORS
2023-11-14
专利权人UNIV TOMSK POLYTECHNIC (UYTO-C)
申请日期2023-11-14
专利号RU2826247-C1
成果简介NOVELTY - Invention relates to the field of radiopharmaceuticals intended for use as theranostic agents for diagnostics and therapy of tumors expressing on HER2 receptors. Disclosed is a compound for producing a complex with a radionuclide label for theranostics of tumors with hyperexpression of epidermal growth factor type 2 (HER2) of general formula ADAPT6-(SSSG)3-ABD035-GSSC-DOTAGA and a complex comprising a compound according to claim 1 with radionuclide mark, which is 177Lu radionuclide. USE - Organic chemistry; medical chemistry; oncology. ADVANTAGE - Wider range of theranostic agents for selective targeting and penetration into pathogenic tumor tissues, with optimal characteristics for targeted radionuclide therapy of tumors with hyperexpression of epidermal growth factor type 2 (HER2). 2 cl, 2 ex
IPC 分类号A61K-103/30 ; A61K-051/08 ; A61P-035/00 ; C07K-014/315 ; C07K-014/76
国家俄罗斯
专业领域生物科学
语种英语
成果类型专利
文献类型科技成果
条目标识符http://119.78.100.226:8889/handle/3KE4DYBR/19276
专题中国科学院新疆生态与地理研究所
作者单位
UNIV TOMSK POLYTECHNIC (UYTO-C)
推荐引用方式
GB/T 7714
TOLMACHEV V M,YUSUBOV M S O,CHERNOV V I,et al. COMPOUND AND ITS COMPLEX WITH RADIONUCLIDE less than sup greater than 177 less than /sup greater than Lu FOR THERANOSTICS OF TUMORS EXPRESSING ON HER2 RECEPTORS. RU2826247-C1[P]. 2023.
条目包含的文件
条目无相关文件。
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。